These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 38730286)

  • 1. Choline metabolism reprogramming mediates an immunosuppressive microenvironment in non-small cell lung cancer (NSCLC) by promoting tumor-associated macrophage functional polarization and endothelial cell proliferation.
    Xiao B; Li G; Gulizeba H; Liu H; Sima X; Zhou T; Huang Y
    J Transl Med; 2024 May; 22(1):442. PubMed ID: 38730286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spatial interaction and functional status of CD68
    Liu X; Zhang Z; Yuan J; Yu J; Chen D
    Front Immunol; 2024; 15():1396719. PubMed ID: 38799432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated Analysis Construct a Tumor-Associated Macrophage Novel Signature with Promising Implications in Predicting the Prognosis and Immunotherapeutic Response of Gastric Cancer Patients.
    Xin H; Chen Y; Niu H; Li X; Gai X; Cui G
    Dig Dis Sci; 2024 Jun; 69(6):2055-2073. PubMed ID: 38573378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic model based on B cell marker genes for NSCLC patients under neoadjuvant immunotherapy by integrated analysis of single-cell and bulk RNA-sequencing data.
    Liu Y; Bie F; Bai G; Huai Q; Li Y; Chen X; Zhou B; Gao S
    Clin Transl Oncol; 2024 Aug; 26(8):2025-2036. PubMed ID: 38563846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Role of COX-2/PGE2/EP4 Axis-induced Macrophage Functional Activation 
in NSCLC Development].
    Zhao J; Zhu Q; Zhang Y; Li G; Zhang Y; Li F; Bian L
    Zhongguo Fei Ai Za Zhi; 2024 Apr; 27(4):245-256. PubMed ID: 38769827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of tertiary lymphoid structures on tumor prognosis and the immune microenvironment in non-small cell lung cancer.
    Weng Y; Yuan J; Cui X; Wang J; Chen H; Xu L; Chen X; Peng M; Song Q
    Sci Rep; 2024 Jul; 14(1):16246. PubMed ID: 39009684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor microenvironment characteristics of lipid metabolism reprogramming related to ferroptosis and EndMT influencing prognosis in gastric cancer.
    Zhao Q; Yu H; Shi M; Wang X; Fan Z; Wang Z
    Int Immunopharmacol; 2024 Aug; 137():112433. PubMed ID: 38870879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ASCC3 promotes the immunosuppression and progression of non-small cell lung cancer by impairing the type I interferon response via CAND1-mediated ubiquitination inhibition of STAT3.
    Ao YQ; Gao J; Jin C; Wang S; Zhang LC; Deng J; Chen ZW; Wang HK; Jiang JH; Ding JY
    J Immunother Cancer; 2023 Dec; 11(12):. PubMed ID: 38148115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Revealing prognostic insights of programmed cell death (PCD)-associated genes in advanced non-small cell lung cancer.
    Dong W; Zhang H; Han L; Zhao H; Zhang Y; Liu S; Zhang J; Niu B; Xiao W
    Aging (Albany NY); 2024 May; 16(9):8110-8141. PubMed ID: 38728242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real-world comprehensive genomic and immune profiling reveals distinct age- and sex-based genomic and immune landscapes in tumors of patients with non-small cell lung cancer.
    Wallen ZD; Ko H; Nesline MK; Hastings SB; Strickland KC; Previs RA; Zhang S; Pabla S; Conroy J; Jackson JB; Saini KS; Jensen TJ; Eisenberg M; Caveney B; Sathyan P; Severson EA; Ramkissoon SH
    Front Immunol; 2024; 15():1413956. PubMed ID: 38975340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentially functional genetic variants in the complement-related immunity gene-set are associated with non-small cell lung cancer survival.
    Qian D; Liu H; Wang X; Ge J; Luo S; Patz EF; Moorman PG; Su L; Shen S; Christiani DC; Wei Q
    Int J Cancer; 2019 Apr; 144(8):1867-1876. PubMed ID: 30259978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anoikis-related gene signature is associated with immune infiltration and predicts the prognosis of non-small cell lung cancer.
    Wu Y; Zhou Z; Qi Q; Xu S; Chen L; Wang F
    Aging (Albany NY); 2024 Feb; 16(3):2908-2933. PubMed ID: 38329444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decoding temporal heterogeneity in NSCLC through machine learning and prognostic model construction.
    Cheng J; Xiao M; Meng Q; Zhang M; Zhang D; Liu L; Jin Q; Fu Z; Li Y; Chen X; Xie H
    World J Surg Oncol; 2024 Jun; 22(1):156. PubMed ID: 38872167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of the tumor microenvironment and mechanism of immunotherapy-based drug resistance in breast cancer.
    Kundu M; Butti R; Panda VK; Malhotra D; Das S; Mitra T; Kapse P; Gosavi SW; Kundu GC
    Mol Cancer; 2024 May; 23(1):92. PubMed ID: 38715072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low densities of immune cells indicate unfavourable overall survival in patients suffering from squamous cell carcinoma of the lung.
    Steffens S; Kayser C; Roesner A; Rawluk J; Schmid S; Gkika E; Kayser G
    Sci Rep; 2024 Jun; 14(1):14250. PubMed ID: 38902361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Cancer Cell Dissemination Machinery as an Immunosuppressive Niche: A New Obstacle Towards the Era of Cancer Immunotherapy.
    Asiry S; Kim G; Filippou PS; Sanchez LR; Entenberg D; Marks DK; Oktay MH; Karagiannis GS
    Front Immunol; 2021; 12():654877. PubMed ID: 33927723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel insight into cancer therapy: Lipid metabolism in tumor-associated macrophages.
    Ren Y; Wang M; Yuan H; Wang Z; Yu L
    Int Immunopharmacol; 2024 Jun; 135():112319. PubMed ID: 38801810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Biological Role of Macrophage in Lung and Its Implications in Lung Cancer Immunotherapy.
    Wang C; Gao Q; Wu J; Lu M; Wang J; Ma T
    Adv Biol (Weinh); 2024 Jun; 8(6):e2400119. PubMed ID: 38684453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of resistance to targeted therapy and immunotherapy in non-small cell lung cancer: promising strategies to overcoming challenges.
    Xiang Y; Liu X; Wang Y; Zheng D; Meng Q; Jiang L; Yang S; Zhang S; Zhang X; Liu Y; Wang B
    Front Immunol; 2024; 15():1366260. PubMed ID: 38655260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-cell and spatial transcriptomics analysis of non-small cell lung cancer.
    De Zuani M; Xue H; Park JS; Dentro SC; Seferbekova Z; Tessier J; Curras-Alonso S; Hadjipanayis A; Athanasiadis EI; Gerstung M; Bayraktar O; Cvejic A
    Nat Commun; 2024 May; 15(1):4388. PubMed ID: 38782901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.